2-oxygen containing heteroalkoxyalkyl dihydropyridine intermediates
AssigneePfizer Inc.
InventorsDavid Alker, Simon F. Campbell, Peter E. Cross
Life of this patent
Estimating the term…
Loading patent…
AssigneePfizer Inc.
InventorsDavid Alker, Simon F. Campbell, Peter E. Cross
Estimating the term…
1,4-Dihydropyridine anti-ischaemic and antihypertensive agent of the formula: ##STR1## or a pharmaceutically acceptable salt thereof, wherein R is 2-chlorophenyl, 2,3-dichlorophenyl or 2-chloro-3-trifluoromethylphenyl; R.sup.1 and R.sup.2 are each independently C.sub.1 -C.sub.4 alkyl; X is O or S; R.sup.3 is H or C.sub.1 -C.sub.4 alkyl; and R.sup.4 is 1,2,4-triazol-1-ylmethyl, imidazol-1-ylmethyl, azidomethyl, 2,4,5-trimethylimidazol-1-ylmethyl, 3,4-dihydro-4-oxopyrimidin-2-ylthiomethyl, pyrimidin-2-ylthiomethyl; pyrimidin-2-ylaminomethyl, 3,4-dihydro-4-oxopyrimidin-2-ylaminomethyl, 2-aminopyrimidin-4-yloxymethyl, methoxymethyl, 2-furyl, 2-pyridylmethyl, imidazol-2-yl, hydroxymethyl, aminomethyl, 1,2,4-triazol-4-ylmethyl or 2-hydroxyethyl, and intermediates leading thereto.
A compound of the formula ##STR39## wherein R is selected from the group consisting of 2-chlorophenyl, 2,3-dichlorophenyl and 2-chloro-3-trifluoromethylphenyl;
A compound of the formula ##STR40## wherein R is slected from the group consisting of 2-chlorophenyl, 2,3-dichlorophenyl and 2-chloro-3-trifluoromethylphenyl;
Dependencies are inferred from the claim text.